Beijing Yijie Pharmaceutical

Beijing Yijie Pharmaceutical Technology Co., Ltd. (BYPT) is a specialized pharmaceutical and medical device company based in Beijing, China, focused on innovative ophthalmic treatments. As a key affiliate of the Sunflower Pharmaceutical Group, BYPT develops and commercializes advanced therapies for visual function disorders, including myopia and dry eye. The company is a primary strategic partner for Japan's Tsubota Lab, holding exclusive rights to develop and market the TLG-001 violet light exposure device and several pharmaceutical assets in the Greater China region. BYPT's pipeline includes both medical devices and small molecule eye drops aimed at addressing the global myopia epidemic.